Emergent Biosolutions Inc. Stock
Heavy losses for Emergent Biosolutions Inc. today as the stock fell by -€0.204 (-4.490%).
With 2 Buy predictions and 3 Sell predictions the community is currently undecided on Emergent Biosolutions Inc..
A slightly negative potential of -8.65% at a current price of 4.38 € for Emergent Biosolutions Inc. is the result of a target price of 4 €.
For the coming years our community has positive and negative things to say abot the Emergent Biosolutions Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. | -4.490% | -14.305% | 115.396% | -44.145% | 96.544% | -90.671% | -88.762% |
Ironwood Pharmaceuticals | -7.500% | -4.310% | -25.503% | -44.221% | -45.588% | -45.050% | - |
Novocure Ltd | 4.840% | 5.435% | 89.436% | -71.271% | 49.492% | -85.644% | - |
Iovance Biotherapeutics Inc. | -2.500% | -2.040% | -15.627% | 22.927% | 18.110% | -36.836% | - |
Comments
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Show more
Ratings data for EBS provided by MarketBeat